| |
In an effort
to enrich and prolong the life of cancer patients through
cost-effective therapies, Shantha has launched the CYTOCREST
initiative.
Under this initiative, Shantha will introduce several new
generation Oncocare products which will be either developed
in-house or through alliances with major pharmaceutical
companies.
The whole gamut of therapies in cancer care has been planned
under the flagship of CYTOCREST which includes Chemotherapeutics,
Biological Therapy and Supportive Therapy, for marketing in India only.
|
|